Evommune EVMN Stock Issued During Period Value Conversion Of Preferred Stock
Stock Issued During Period Value Conversion Of Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:StockIssuedDuringPeriodValueConversionOfPreferredStock.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's stock issued during period value conversion of preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's stock issued during period value conversion of preferred stock?
- Evommune (EVMN) reported stock issued during period value conversion of preferred stock of $313.2K in Q4 2025.
- What does stock issued during period value conversion of preferred stock mean?
- Represents the dollar value of common stock issued as a result of the conversion of preferred equity into common shares. This transaction reflects a change in the capital structure where senior equity is exchanged for common equity. It provides insight into the reduction of preferred dividend obligations and the resulting increase in common share count.